KIM
CELU icon

Karpus Investment Management’s Celularity CELU Stock Holding History

Karpus Investment Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-42,195
Closed -$4.2M – 229
2019
Q4 		$4.2M Buy
+42,195
New +$4.18M 0.14% 104

Other funds holding CELU

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Karpus Investment Management's CELU Position: Q1 2020 in Review

Karpus Investment Management sold out of Celularity (CELU) in Q1 2020, closing a stake of 42,195 shares — an estimated $4.2M sold.

Karpus Investment Management first reported a position in CELU in Q4 2019 and held it in 1 quarter. The position peaked at $4.2M in Q4 2019. 35 funds tracked by Wall St. Rank hold CELU as of Q1 2020.

  • Karpus Investment Management reported no remaining Celularity position as of Q1 2020 after selling out during the quarter.
  • Karpus Investment Management sold 42,195 Celularity shares in Q1 2020, an estimated $4.2M.
  • Karpus Investment Management first reported a position in Celularity in Q4 2019 and held it in 1 quarter.
  • Karpus Investment Management's Celularity position peaked at $4.2M in Q4 2019.
  • 35 funds tracked by Wall St. Rank held Celularity as of Q1 2020.

Based on Karpus Investment Management's 13F filing for Q1 2020, filed 18 May 2020.